Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
2.
Surgery ; 157(6): 1073-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25712200

ABSTRACT

BACKGROUND: In 2009, a study from our institution used retrospective data and multivariate analysis to identify 5 quantitative variables and their cutoffs that have a positive predictive value (PPV) for common bile duct (CBD) stones in gallstone pancreatitis. They also proposed a management protocol based on the scoring system. This prospective study sought to validate that scoring system. METHODS: From October 2009 to August 2013, patients with gallstone pancreatitis were enrolled in the study. Scores of 0-5 were determined at admission, with 1 point for each criterion met: CBD ≥ 9 mm, gamma glutamyltransferase ≥ 350 U/L, alkaline phosphatase ≥ 250 U/L, total bilirubin ≥ 3 mg/dL, and direct bilirubin ≥ 2 mg/dL. All CBDs were assessed using intraoperative cholangiogram, MR cholangiopancreatography (MRCP), or endoscopic retrograde cholangiopancreatography (ERCP). RESULTS: Of 84 patients, 16 had CBD stones. A score of 0 had negative predictive value (NPV) of 100% for CBD stones (P < .001). Scores of 1 and 2 had NPV of 81% and 83%, respectively. A score of 3 had NPV of 60%. A score of 4 had PPV of 67% (P = .002). A score of 5 had PPV of 100% (P < .001). The overall accuracy of the scoring system was 88%. CONCLUSION: The scoring system is accurate in prediction of CBD stones in patients with gallstone pancreatitis. We propose that patients with 0 points undergo laparoscopic cholecystectomy, 1 and 2 points undergo laparoscopic cholecystectomy with intraoperative cholangiogram, 3 and 4 points undergo MRCP, and 5 points undergo ERCP as the first step in management for gallstone pancreatitis. The proposed protocol eliminated negative ERCPs.


Subject(s)
Cholecystectomy, Laparoscopic/methods , Clinical Protocols/standards , Gallstones/diagnosis , Gallstones/surgery , Pancreatitis/diagnosis , Pancreatitis/surgery , Academic Medical Centers , Adult , Aged , Cholangiopancreatography, Endoscopic Retrograde/methods , Cholecystectomy, Laparoscopic/adverse effects , Common Bile Duct/diagnostic imaging , Common Bile Duct/surgery , Evaluation Studies as Topic , Female , Follow-Up Studies , Gallstones/complications , Humans , Male , Middle Aged , Monitoring, Intraoperative/methods , Multivariate Analysis , New York City , Pancreatitis/complications , Postoperative Complications/diagnostic imaging , Postoperative Complications/surgery , Predictive Value of Tests , Quality Improvement , Retrospective Studies , Risk Assessment , Severity of Illness Index , Sphincterotomy, Endoscopic/adverse effects , Sphincterotomy, Endoscopic/methods , Treatment Outcome
3.
J Surg Oncol ; 102(6): 704-5, 2010 Nov 01.
Article in English | MEDLINE | ID: mdl-20721964

ABSTRACT

Glomerulopathy is a rare form of paraneoplastic disease. We present the second reported case of paraneoplastic glomerulopathy due to a retroperitoneal sarcoma. The patient presented with generalized edema and nephrotic syndrome. CT scan showed two large retroperitoneal masses. One large retroperitoneal mass was resected. Post-operatively, she developed kidney failure and biopsy showed minimal change disease. With steroid therapy, patient's symptoms went into remission. We hypothesize that minimal change paraneoplastic glomerulopathy developed due to damage from cytokines released from a T-cell mediated response to the malignancy.


Subject(s)
Sarcoma/complications , Adult , Female , Humans , Nephrosis, Lipoid/complications , Paraneoplastic Syndromes/complications , Retroperitoneal Neoplasms/complications
SELECTION OF CITATIONS
SEARCH DETAIL